The programs must be hospitalwide and adhere to nationally recognized guidelines on the surveillance and prevention of healthcare-associated infections, along with the optimization of antibiotic use.
Hospitals will have six months to implement a program after the final rule is published in the Federal Register.
“The changes are aimed at effectively reducing the development and transmission of HAIs and antibiotic-resistant organisms that ultimately will greatly improve the care and safety of patients while adding cost benefits for hospitals,” CMS said in a fact sheet.
More articles on infection control:
43 Minnesota hospitals recognized for high employee flu shot rates
Connecticut reports first EEE death since 2013
CDC: Deer can spread tuberculosis to humans
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
